Morgan Stanley »

Singular Genomics Systems In shares owned by Morgan Stanley

Quarter-by-quarter ownership of Singular Genomics Systems In shares owned by Morgan Stanley from 13F filings

Historical chart of Morgan Stanley investment in Singular Genomics Systems In

Tip: Access up to 7 years of quarterly data

All positions including Singular Genomics Systems In held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Singular Genomics Systems In by Morgan Stanley

Quarter filed Position value Share count Share price at filing
2024-06-30 $3.1k 363 8.45

More positions owned by Morgan Stanley

Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Meta Platforms Cl A (META)
JPMorgan Chase & Co. (JPM)
Alphabet Cap Stk Cl C (GOOG)
Visa Com Cl A (V)
Eli Lilly & Co. (LLY)
Ishares Tr Core S&p500 Etf (IVV)
Broadcom (AVGO)
UnitedHealth (UNH)
Berkshire Hathaway Inc Del Cl B New (BRK.B)

View all positions for Morgan Stanley

Top funds holding Singular Genomics Systems In

Deerfield Management Company
Arch Venture Corp
QVIDTVM Management
Perceptive Advisors
Vanguard Group
Casdin Capital
BlackRock
OrbiMed Advisors
HighTower Advisors
Geode Capital Management
Tikvah Management
Tower Research Capital
Barclays
Bank of America Corporation
Morgan Stanley

View all funds holding Singular Genomics Systems In